AwardedSpainGoods
SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS: BULEVIRTIDA (HEPCLUDEX).
- Published
- Published 29 September 2025
Overview
The Madrid Health Service at La Paz University Hospital procured the supply of the exclusive medication Bulevirtida (Hepcludex), a drug used for hepatitis D treatment. The contract was awarded to Gilead Sciences, S.L. on 25 August 2025 for €236,823.87.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 29 September 2025
Pharmaceutical products
Award outcome
- Awarded value
- €236,824
- Award date
- 25 August 2025
- Contract period
- — → 21 February 2026
- GILEAD SCIENCES, S.L.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
29 September 2025
Contracting authority
Servicio Madrileno de Salud, Hospital Universitario La Paz
Procuring entityMadrid, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.